Description: XPhyto Therapeutics Corp., through its subsidiaries, operates in the medicinal cannabis industry in Canada and Germany. It is involved in the production, extraction, isolation, formulation, delivery, marketing, and sale of medicinal cannabis. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
Home Page: xphyto.com
1820 Fir Street
Vancouver,
BC
V6J 3B1
Canada
Phone:
780 818 6422
Officers
| Name | Title |
|---|---|
| Mr. Hugh A. D. Rogers B.Sc., LL.B | Pres, CEO & Director |
| Mr. Patrick Joseph Meagher | Chief Financial Officer |
| Dr. Thomas Beckert | Managing Director of XP Diagnostics GmbH & Vektor Pharma TF GmbH |
| Dr. Heinrich Jehle | Head of Diagnostic Research |
| Dr. Florian A. Sahr | Head of Project Management |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 16.0129 |
| Price-to-Sales TTM: | 89.8628 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |